FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087935695> ?p ?o ?g. }

• W2087935695 endingPage "935" @default.
• W2087935695 startingPage "931" @default.
• W2087935695 abstract "BACKGROUND : Bone marrow transplant (BMT) patients, although immunosuppressed, are at risk for the development of red cell (RBC) and HLA antibodies, and they often are given filtered blood in an effort to prevent the latter complication. This study attempts to determine the rate of formation and the specificity of both RBC and HLA alloantibodies in this patient population. STUDY DESIGN AND METHODS : BMT patients (148 received autologous marrow; 45 received allogeneic marrow) from an 18‐month period, including patients with leukemia (57 patients), lymphoma (54), breast cancer (68), myeloma (8), myelodysplastic syndrome (5), and aplastic anemia (1), were studied to determine the rate of alloantibody formation to RBC and HLA antigens. A total of 2,410 RBC antibody screens were performed. The patients received 3,921 packed RBCs and 5,915 single‐donor platelet units; all were irradiated and administered via white cell‐reduction filters. RESULTS : Seven (3.6%) of 193 patients had RBC antibodies upon hospital admission. Four (2.1%) of 193 developed RBC antibodies during the course of BMT: 3 patients had one RBC antibody and 1 patient had two RBC antibodies. RBC antibodies included anti‐E (n = 2), anti‐M (n = 1), anti‐Jkb (n = 1), and anti‐Lu14 (n = 1). Thus, 98 percent of patients (189/193) did not develop new (182/186) or additional (7/7) RBC antibodies during BMT. BMT patients were also screened weekly for HLA antibody formation (60‐cell panel). Upon admission, 170 (85%) patients were negative. Of these, 8 (4.7%) developed persistent HLA antibodies (mean panel‐reactive antibody score, 33 +/− 29%) and 9 (5.3%) were variably positive. Thus, in our setting and population, RBC antibody formation was 0.1 percent per unit transfused, and the HLA alloimmunization rate was 5 to 10 percent. CONCLUSION : As RBC antibody screens are done every Monday, Wednesday, and Friday on this BMT service and as RBC antibody formation is low in these patients, screening for unexpected antibodies might be possible on a more infrequent basis. Also, the rate of HLA alloimmunization in this population receiving filtered blood components is low." @default.
• W2087935695 created "2016-06-24" @default.
• W2087935695 creator A5000022245 @default.
• W2087935695 creator A5001898266 @default.
• W2087935695 creator A5013622031 @default.
• W2087935695 creator A5016744883 @default.
• W2087935695 creator A5031181626 @default.
• W2087935695 creator A5036306540 @default.
• W2087935695 creator A5045446622 @default.
• W2087935695 creator A5063740855 @default.
• W2087935695 creator A5072741463 @default.
• W2087935695 creator A5086706905 @default.
• W2087935695 date "1995-11-12" @default.
• W2087935695 modified "2023-10-12" @default.
• W2087935695 title "Low incidence of red cell and HLA antibody formation by bone marrow transplant patients" @default.
• W2087935695 cites W168192535 @default.
• W2087935695 cites W1868479675 @default.
• W2087935695 cites W1972222010 @default.
• W2087935695 cites W1976293536 @default.
• W2087935695 cites W1990482654 @default.
• W2087935695 cites W1997383640 @default.
• W2087935695 cites W2009558210 @default.
• W2087935695 cites W2016235896 @default.
• W2087935695 cites W2038566424 @default.
• W2087935695 cites W2041988868 @default.
• W2087935695 cites W2044164695 @default.
• W2087935695 cites W2047774687 @default.
• W2087935695 cites W2055473856 @default.
• W2087935695 cites W2065877867 @default.
• W2087935695 cites W2067143062 @default.
• W2087935695 cites W2083888536 @default.
• W2087935695 cites W2088254510 @default.
• W2087935695 cites W2122608902 @default.
• W2087935695 cites W2152755856 @default.
• W2087935695 cites W2165811661 @default.
• W2087935695 cites W2194721788 @default.
• W2087935695 cites W2317096380 @default.
• W2087935695 cites W2345802622 @default.
• W2087935695 cites W27728380 @default.
• W2087935695 cites W4246395665 @default.
• W2087935695 cites W43241374 @default.
• W2087935695 doi "https://doi.org/10.1046/j.1537-2995.1995.351196110898.x" @default.
• W2087935695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8604491" @default.
• W2087935695 hasPublicationYear "1995" @default.
• W2087935695 type Work @default.
• W2087935695 sameAs 2087935695 @default.
• W2087935695 citedByCount "58" @default.
• W2087935695 countsByYear W20879356952012 @default.
• W2087935695 countsByYear W20879356952013 @default.
• W2087935695 countsByYear W20879356952014 @default.
• W2087935695 countsByYear W20879356952015 @default.
• W2087935695 countsByYear W20879356952016 @default.
• W2087935695 countsByYear W20879356952019 @default.
• W2087935695 countsByYear W20879356952020 @default.
• W2087935695 countsByYear W20879356952021 @default.
• W2087935695 countsByYear W20879356952022 @default.
• W2087935695 crossrefType "journal-article" @default.
• W2087935695 hasAuthorship W2087935695A5000022245 @default.
• W2087935695 hasAuthorship W2087935695A5001898266 @default.
• W2087935695 hasAuthorship W2087935695A5013622031 @default.
• W2087935695 hasAuthorship W2087935695A5016744883 @default.
• W2087935695 hasAuthorship W2087935695A5031181626 @default.
• W2087935695 hasAuthorship W2087935695A5036306540 @default.
• W2087935695 hasAuthorship W2087935695A5045446622 @default.
• W2087935695 hasAuthorship W2087935695A5063740855 @default.
• W2087935695 hasAuthorship W2087935695A5072741463 @default.
• W2087935695 hasAuthorship W2087935695A5086706905 @default.
• W2087935695 hasConcept C126322002 @default.
• W2087935695 hasConcept C147483822 @default.
• W2087935695 hasConcept C159654299 @default.
• W2087935695 hasConcept C188280979 @default.
• W2087935695 hasConcept C203014093 @default.
• W2087935695 hasConcept C2776364478 @default.
• W2087935695 hasConcept C2778461978 @default.
• W2087935695 hasConcept C2779338263 @default.
• W2087935695 hasConcept C2780007613 @default.
• W2087935695 hasConcept C2781440808 @default.
• W2087935695 hasConcept C71924100 @default.
• W2087935695 hasConcept C90924648 @default.
• W2087935695 hasConceptScore W2087935695C126322002 @default.
• W2087935695 hasConceptScore W2087935695C147483822 @default.
• W2087935695 hasConceptScore W2087935695C159654299 @default.
• W2087935695 hasConceptScore W2087935695C188280979 @default.
• W2087935695 hasConceptScore W2087935695C203014093 @default.
• W2087935695 hasConceptScore W2087935695C2776364478 @default.
• W2087935695 hasConceptScore W2087935695C2778461978 @default.
• W2087935695 hasConceptScore W2087935695C2779338263 @default.
• W2087935695 hasConceptScore W2087935695C2780007613 @default.
• W2087935695 hasConceptScore W2087935695C2781440808 @default.
• W2087935695 hasConceptScore W2087935695C71924100 @default.
• W2087935695 hasConceptScore W2087935695C90924648 @default.
• W2087935695 hasIssue "11" @default.
• W2087935695 hasLocation W20879356951 @default.
• W2087935695 hasLocation W20879356952 @default.
• W2087935695 hasOpenAccess W2087935695 @default.
• W2087935695 hasPrimaryLocation W20879356951 @default.
• W2087935695 hasRelatedWork W1970895673 @default.
• W2087935695 hasRelatedWork W1987867897 @default.

• next